GC31474
Risarestat
Also listed as Risarestat (CT 112)
Risarestat (CT 112) (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications
ChemicalCAS79714-31-1MW323.41FormulaC16H21NO4S
- CAS number
- 79714-31-1
- Molecular weight
- 323.41
- Formula
- C16H21NO4S
- Solubility
- DMSO ： 105 mg/mL (324·67 mM; Need ultrasonic)
- InChIKey
- CRPGRUONUFDYBG-UHFFFAOYSA-N
- Catalogue number
- GC31474
- Brand
- GLPBIO
Computed properties PubChem CID 133264 · XLogP 3.9 · TPSA 89.9 Ų · H-bond donors 1
- XLogP
- 3.9
- TPSA
- 89.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 8
- Heavy atoms
- 22
SMILES CCCCCOC1=C(C=C(C=C1)C2C(=O)NC(=O)S2)OCC
Computed descriptors from PubChem (CID 133264), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il